In long-term follow-up of KEEPsAKE 1 and 2, risankizumab maintained joint<\/b>, skin, pain<\/b>, and axial responses in patients with PsA through 244 weeks.
\nSource: joint pain relief<\/p>\n","protected":false},"excerpt":{"rendered":"
In long-term follow-up of KEEPsAKE 1 and 2, risankizumab maintained joint, skin, pain, and axial responses in patients with PsA through 244 weeks. Source: joint pain relief<\/p>\n","protected":false},"author":1,"featured_media":156391,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15100],"tags":[71],"class_list":["post-493180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-daily-articles","tag-aurum"],"_links":{"self":[{"href":"https:\/\/tpgold.com\/index.php?rest_route=\/wp\/v2\/posts\/493180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tpgold.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tpgold.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tpgold.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tpgold.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=493180"}],"version-history":[{"count":0,"href":"https:\/\/tpgold.com\/index.php?rest_route=\/wp\/v2\/posts\/493180\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tpgold.com\/index.php?rest_route=\/wp\/v2\/media\/156391"}],"wp:attachment":[{"href":"https:\/\/tpgold.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=493180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tpgold.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=493180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tpgold.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=493180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}